Group B streptococcus (Q33534378)

27 July 2017

1 reference

title

Group B streptococcus. (English)

1 reference

27 July 2017

1

A Schuchat

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

353

1 reference

27 July 2017

issue

9146

1 reference

27 July 2017

page(s)

51-56

1 reference

Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Potential consequences of widespread antepartal use of ampicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Prevention of early-onset neonatal group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish Chlorhexidine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Premature rupture of the fetal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Risk Factors for Group B Streptococcal Disease in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

The Role of Maternal Syphilis, Gonorrhoea and HIV-1 Infections in Spontaneous Abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Maternal carriage of group B streptococci in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Chlamydia trachomatis infection and pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Risk of preterm delivery in pregnant women with group B streptococcal urinary infections or urinary antibodies to group B streptococcal and E. coli antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Group B streptococcal colonisation and the outcome of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Group B streptococcus and premature rupture of membranes and preterm delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A prevention program based on bacteriological and immunological follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Group B streptococci in the lower urogenital tract and late abortions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Neonatal septicemia due to group B streptococci--perinatal risk factors and outcome of subsequent pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Randomized study of vaginal chlorhexidine disinfection during labor to prevent vertical transmission of group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Intrapartum chemoprophylaxis of early-onset group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Single-dose penicillin prophylaxis of neonatal group-B-streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Ampicillin Prevents Intrapartum Transmission of Group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. II. Predictive Value of Prenatal Cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Group B streptococcal carriage and disease: a 6-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

The accuracy and patient preference for self-collected group B Streptococcus cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Sexual behavior and vaginal colonization by group B streptococcus among minority women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Epidemiology of Group B Streptococcus: Longitudinal Observations during Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Invasive group B streptococcal disease: the emergence of serotype V

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. I. Epidemiologic Rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Puerperal and perinatal infections with group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Group B streptococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Seroepidemiology of group B streptococcus type III colonization at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Electron Microscopic Definition of Surface Antigens of Group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Antibody responses in invasive group B streptococcal infection in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Impact of a risk-based prevention policy on neonatal group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Neonatal group B streptococcal infection in a managed care population. Perinatal Group B Streptococcal Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Neonatal Group B Streptococcal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907128-1

7 January 2021

10.1016/S0140-6736(98)07128-1

Identifiers

DOI

1 reference

27 July 2017

1 reference